Kunezinkinga eziningi ezingaphezulu kwamathumbu ezingase zenzeke ngesifo sofuba (IBD) esibandakanya isifo samathambo , isifo sesibindi, ukuphazamiseka kokudla okunomsoco, i- anemia , kanye nezifo zesikhumba. Izifo zesikhumba yinkinga ejwayelekile, futhi ingathinta amaphesenti angu-25 abantu abahlala ne-IBD. Uhlobo olulodwa lwesifo sesikhumba esingase sibe khona kwiziguli ezine-IBD yi-pyoderma gangrenosum.
Kungenzeka ukuthi umuntu onesifo se-pyoderma gangrenosum ekuqaleni angaphathwa kabi uma ochwepheshe bezempilo bebheke izilonda esikhumbeni akuxhumeki ku-IBD. Lokhu kungasho ukuthi ukwelashwa okusetshenziswe ekuqaleni akuphumelelanga. Yingakho kubaluleke kangaka ukuthi abantu abane-IBD bakhuphuke ku-gastroenterologist nganoma yiziphi izinkinga ezintsha, ngisho noma ekuqaleni babonakala bengathinti izifo zesisu. Isazi se-IBD noma udokotela we-dermatologist onokuhlangenwe nakho neziguli ezine-IBD kungadinga ukubonisana ukuze enze ukuxilongwa okufanele futhi uthole ukwelashwa kuqala.
Sibutsetelo
I-Pyoderma gangrenosum yinkinga yesikhumba echaphazela ngamaphesenti angu-5 abantu abane-ulcerative colitis kanye namaphesenti angu-1 abantu abane-Crohn's disease. Ezinye zezinye izifo ezihlobene ne-pyoderma gangrenosum zihlanganisa i-rheumatoid arthritis, i-myeloid blood dyscrasias, ne-hepatitis. I-Pyoderma gangrenosum ingabonakala kuqala njenge-blister, i-red bump, noma i-pustule futhi ingaba yinto ebukeka sengathi ingaphilisa yedwa.
Nokho, lesi sifo asiphilisi futhi ekugcineni sakha isilonda. Izilonda zingase zivele zodwa noma eqenjini futhi zivame ukutholakala emikhawulweni, kodwa zivela kaningi emilenzeni kunokuba zenze izingalo.
Iqala kanjani
I-Pyoderma gangrenosum ingase iqale ngokushesha endaweni yokulimala okuncane okwedlulele esikhumbeni, njenge-scrape, pinprick, noma ukusika.
Isikhumba esizungezile sihlehla phansi, futhi isilonda sisheshe sifake. I-Pyoderma gangrenosum ulcers inemiphetho ehlukile, enemibala engacacile. Futhi bavame ukuba buhlungu futhi bephuze ukuphulukisa. Odokotela abaqiniseki ukuthi yini ebangela i-pyoderma gangrenosum kodwa bathi i-autoimmune isimo, ngoba ihlobene nezinye izifo ezizimele.
Indlela i-Pyoderma Gangrenosum ehlobene ngayo ne-IBD
Amaphesenti angu-50 amacala we-pyoderma gangrenosum akhona kubantu abanehlobo olulodwa lwe-IBD. Ngezinye izikhathi, ukutholakala kwalezi zilonda kufana nokuvuleka okusebenzayo kwe-IBD futhi kungaphendula lapho i-IBD ephathekayo iphathwa ngokuphumelelayo. Ezinye izimo, kodwa-ke, azibonakali zihlobene ngqo nomsebenzi wesifo, kanti i-pyoderma gangrenosum ingaqala noma ifinyelele nakakhulu uma i-IBD iqubuzela.
Ukwelapha
Ukuqinisekisa ukuxilongwa kwe-pyoderma gangrenosum ngokusebenzisa ukuhlolwa kokuhlola, i-dermatologist ingabonisana. Izilonda zingase zishintshwe futhi zihlonywe ukuze zihlolwe izifo, futhi ama- biopsies angathathwa futhi ahlolwe ukuze abone ezinye izimbangela. Ngenxa yokuthi i-pyoderma gangrenosum ayibangelwa yi-bacterium, ama-antibiotic angeke aphumelele njengokwelashwa.
Izilonda ezincane ezincane ze-pyoderma gangrenosum zingaphathwa nge:
- Ukunamathisela ukucindezela
- I-steroid creams noma ama-injection
- Ama-antibiotic omlomo anqanda ukuvuvukala
- Ukugqoka isiliva sulfadiazine ukhilimu noma i-hydrocolloids
Izilonda ezinkulu ezinokwelashwa okuphikisana nazo zingadinga ukwelashwa okunamandla nge:
- I-Steroids
- I-Cyclosporine
- Cyclophosphamide
- I-Methotrexate
- Amafutha Tacrolimus
Ngaphansi
Uma une-lesion esolisayo noma engayikuphulukisa, bheka udokotela wakho wokunakekela oyinhloko noma isisu se-gastroenterologist ngokushesha ngangokunokwenzeka ukuze udluliselwe kudokotela wesimemezelo. Udokotela wezidakamizwa, okungcono umuntu ohlangene nezinye iziguli ze-IBD, angazihlola kahle futhi aphathe lesi simo sesikhumba.
Imithombo:
I-CCFA. "Ukubonakaliswa okungajwayelekile emzimbeni wesifo sofuba." I-CCFA 1 Meyi 2012.
Papageorgiou KI, Mathew RG, Kaniorou-Larai MG, Yiakoumetis A. "I-Pyoderma gangrenosum e-ulcerative colitis: okucatshangelwa ukuxilongwa kwangaphambili." BMJ December 3 2005.
I-Merck Manual. "I-Pyoderma Gangrenosum." Merck & Co, Inc Feb 2012.